ASNSD1

Across TCGA pan-cancer cohorts, ASNSD1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated ASNSD1 data layer compared with 23 for mass-spec protein and 7 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher ASNSD1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated ASNSD1 expression acts as an unfavorable survival marker, although some lineages such as LUAD and LSCC show a favorable association.

LUAD, LSCC, and GBM are the cancer types where ASNSD1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	III,IV	1.000	0.784	.009	10	view →
LSCC	OS	Median	III,IV	0.983	0.426	.013	7	view →
GBM	DFS	Tertile	All	1.000	0.515	.026	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

ASNSD1–LUAD (OS)

Open the LUAD breakdown →